LGALS1-Associated Candidate Myeloid Signature and In Silico Regulatory Analysis in Ulcerative Colitis: A Bioinformatics Study
Background: Ulcerative colitis (UC) substantially impairs patients’ quality of life and increases the risk of colorectal carcinogenesis. However, its precise molecular pathogenesis remains to be elucidated. Methods: Bioinformatic tools and methods were used to achieve the objectives of this study. We integrated single-cell RNA sequencing (scRNA-seq), bulk transcriptome, genome-wide association study (GWAS), and single-cell expression quantitative trait locus (sc-eQTL) data to comprehensively identify key molecular determinants underlying UC. scPagwas and Scissor analyses were performed to identify the critical cell subpopulations. Subsequently, single-cell Mendelian randomization (scMR) analysis was applied to prioritize the cell-type-specific putative causal genes. The candidate genes were further refined using univariate and multivariate regression analyses. The resulting gene set was incorporated into a machine-learning-based feature gene model, with model interpretability rigorously assessed using Shapley Additive Explanations (SHAPs). Mechanistically, virtual knockout perturbation analysis (scTenifoldKnk) was complemented by CellOracle, CellChat, and pseudotime trajectory analyses. Drug2cell analysis was employed to evaluate the cell-type-specific drug activity of multiple compounds. Results: Myeloid cells emerged as the predominant pathogenic cell subgroup in UC, as identified by scPagwas and Scissor analyses. scMR analysis prioritized 69 myeloid cell-specific putative causal genes associated with UC. Univariate and multivariate regression analyses narrowed this list to four candidate genes. Among them, a three-gene signature comprising galectin 1 (LGALS1), ribosomal protein S25 (RPS25), and N-acylethanolamine acid amidase (NAAA) reached an apparent cross-validated AUC of 0.992 in the training cohort. SHAP interpretation confirmed LGALS1 as the most influential feature in the model. Mechanistic investigations predicted that LGALS1 plays a potential role in modulating myeloid cell differentiation and immune homeostasis in UC. Furthermore, Drug2cell gave higher target-expression-based scores for alpidem, bosutinib and gefitinib in LGALS1-positive monocytes (LGALS1+mono). Conclusions: Collectively, this computational study identifies a candidate three-gene signature (LGALS1, RPS25 and NAAA) and generates hypotheses about LGALS1 in monocyte differentiation in UC.
Authors
- Pei Zhang (ORCID: https://orcid.org/0009-0009-5063-3512)
- Yixuan Wang (ORCID: https://orcid.org/0009-0004-6161-2657)
- Rulan Ma
- Juan Gao
- Xiaoyan Zhang (ORCID: https://orcid.org/0009-0009-2619-9701)
- Shuping Luo
Institutions
- 117th Hospital of People's Liberation Army (CN)
- People's Liberation Army 401 Hospital (CN)
- Chinese People's Liberation Army (CN)
Publication Details
- Journal
- Biomedicines
- Published
- 2026-11-16
- DOI
- https://doi.org/10.3390/biomedicines14112643
- Primary Topic
- Inflammatory Bowel Disease
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Natural Science Foundation of China
- Science and Technology Department of Gansu Province